Inuvo is trading 7.5% down at $0.52, with no clear catalyst identified for the pre-market decline. - The price compares with the September 29 close of $0.56, following a recent string of weaker closes. - The company’s investor news page and available search results did not surface a clear September 30 announcement explaining the move. - The supplied broader market indicators are modestly positive, offering no established market-wide explanation.